Modern pharmaceutical development relies on specific targets and is often narrowly focused. Medisyn's technology can improve development efforts by expanding the target to include critical parameters early in the project such as ADME/Tox, bioavailability, and solubility.
- Bioactivity
- Drug-likeness
- ADME
- Toxicity
